PROGNOSTIC VALUE OF CYCLOOXYGENASE-2 IN CERVIX CANCER PATIENTS

Immunohistochemical detection of cyclooxygenase-2 (СОХ-2) in cervix cancer (CC) patients showed that a significant increase in the overall and relapse-free survival rates in CC patients, regardless of clinical/morphological characteristics is associated with increased expression of CОХ-2 in tumor cells. This suggests that СОХ-2 may be an independent prognostic factor.